Search - tctmd.com

Displaying 441 - 460 of 702

Sort: Relevancy | Date

Manuscript

A New Home for Structural Heart Disease

July 07, 2017

Presentation

Temporal Trends in TAVR: From FRANCE 2 (2010-2012) to FRANCE TAVI (2013-2015)

June 26, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

Presentation TVT 2017

A Friendly Tie on a Hard TAVI

Presenter: David W.M. Muller, Lars Sondergaard, Roman Lezaun, MD

June 16, 2017

Presentation TVT 2017

Looping Against TAVI Leaks: The Magic Tool

Presenter: David W.M. Muller, Lars Sondergaard, Roman Lezaun, MD

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

Spotlight Lecture: The Rapid Emergence of TAVR Programs in Japan - The OCEAN-TAVI Registry

Presenter: Robert O. Bonow, Martin B. Leon, Kentaro Hayashida

June 15, 2017

Presentation TVT 2017

TAVI for Moderate Aortic Stenosis in Cardiogenic Shock and Inotrope Dependence

Presenter: Albert Markus Kasel, Thomas Walther, Hasan Ahmad, MD

June 15, 2017

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Daily News

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Caitlin E. Cox

April 21, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

Presentation JIM 2017

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Presenter: Alberto Cremonesi

February 10, 2017

Presentation JIM 2017

Portico Valve for TAVI

Presenter: Augusto Pichard

February 10, 2017

Presentation JIM 2017

“Evolution of TAVI: transfemoral outcomes using ACURATE neo”

Presenter: Corrado Tamburino

February 09, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

Advertisement

A New Home for Structural Heart Disease

Temporal Trends in TAVR: From FRANCE 2 (2010-2012) to FRANCE TAVI (2013-2015)

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

A Friendly Tie on a Hard TAVI

Looping Against TAVI Leaks: The Magic Tool

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Spotlight Lecture: The Rapid Emergence of TAVR Programs in Japan - The OCEAN-TAVI Registry

TAVI for Moderate Aortic Stenosis in Cardiogenic Shock and Inotrope Dependence

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

More Early Stroke With SAVR Than TAVR in SURTAVI

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Portico Valve for TAVI

“Evolution of TAVI: transfemoral outcomes using ACURATE neo”

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content